{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:36:15Z","timestamp":1782052575515,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bone.2019.115125","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T14:42:24Z","timestamp":1572792144000},"page":"115125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: A practice-level prescribing data analysis in 2013-2018"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3170-7845","authenticated-orcid":false,"given":"Ion","family":"Agirrezabal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0207-4137","authenticated-orcid":false,"given":"Juan M","family":"Cabas\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-3567","authenticated-orcid":false,"given":"Gian Luca","family":"Di Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5320-8732","authenticated-orcid":false,"given":"Eduardo","family":"S\u00e1nchez-Iriso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.115125_bib0005","series-title":"Constitution of the World Health Organization. In.","year":"1948"},{"issue":"9","key":"10.1016\/j.bone.2019.115125_bib0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jech.56.9.647","article-title":"A glossary for health inequalities","volume":"56","author":"Kawachi","year":"2002","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.bone.2019.115125_bib0015","series-title":"Geographical Distribution of Antimicrobial Consumption","year":"2007"},{"issue":"9459","key":"10.1016\/j.bone.2019.115125_bib0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bone.2019.115125_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-6904-7-14","article-title":"Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study","volume":"7","author":"Hartz","year":"2007","journal-title":"BMC Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bone.2019.115125_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010429","article-title":"Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study","volume":"6","author":"Heng","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.bone.2019.115125_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpeds.2015.10.027","article-title":"Prescription use among children with autism Spectrum disorders in Northern New England: intensity and small area variation","volume":"169","author":"House","year":"2016","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.bone.2019.115125_bib0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s15010-012-0302-1","article-title":"Variation in antibiotic prescriptions: is area deprivation an explanation? Analysis of 1.2 million children in Germany","volume":"41","author":"Koller","year":"2013","journal-title":"Infect."},{"key":"10.1016\/j.bone.2019.115125_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2431-9-31","article-title":"Antibiotic use among 8-month-old children in Malmo, Sweden--in relation to child characteristics and parental sociodemographic, psychosocial and lifestyle factors","volume":"9","author":"Mangrio","year":"2009","journal-title":"BMC Pediatr."},{"issue":"559","key":"10.1016\/j.bone.2019.115125_bib0050","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3399\/bjgp09X395076","article-title":"Factors influencing variation in prescribing of antidepressants by general practices in Scotland","volume":"59","author":"Morrison","year":"2009","journal-title":"Br. J. Gen. Pract."},{"issue":"6","key":"10.1016\/j.bone.2019.115125_bib0055","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00228-011-1204-3","article-title":"The regional profile of antibiotic prescriptions in Italian outpatient children","volume":"68","author":"Piovani","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bone.2019.115125_bib0060","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3233\/JAD-160485","article-title":"Geographical variation in antipsychotic drug use in elderly patients with dementia: a nationwide study","volume":"54","author":"Zakarias","year":"2016","journal-title":"J. Alzheimer\u2019s Dis. : JAD"},{"issue":"1","key":"10.1016\/j.bone.2019.115125_bib0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40360-018-0219-0","article-title":"Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation","volume":"19","author":"Islam","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.bone.2019.115125_bib0070","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1186\/s12889-017-4905-4","article-title":"Prevalence of antibiotic prescription in pediatric outpatients in Italy: the role of local health districts and primary care physicians in determining variation. A multilevel design for healthcare decision support","volume":"17","author":"Di Martino","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bone.2019.115125_bib0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2016.10.013","article-title":"Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: variation by age, sex, geographic location and ethnicity","volume":"94","author":"van der Velde","year":"2017","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2019.115125_bib0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00228-013-1615-4","article-title":"Antibiotic and anti-asthmatic drug prescriptions in Italy: geographic patterns and socio-economic determinants at the district level","volume":"70","author":"Piovani","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2019.115125_bib0085","article-title":"Trends in income inequality and its impact on economic growth","volume":"vol. 163","author":"Cingano","year":"2014"},{"key":"10.1016\/j.bone.2019.115125_bib0090","unstructured":"Stronks, G., Gunning-Schepers, L.J.: Should equity in health be target number 1. Eur. J. Public Health (65), 153-165."},{"issue":"10092","key":"10.1016\/j.bone.2019.115125_bib0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(17)31873-1","article-title":"Saving lives with equity-the efficient route to the SDGs","volume":"390","author":"Watkins","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"10156","key":"10.1016\/j.bone.2019.115125_bib0100","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(18)31829-4","article-title":"Revisiting Alma-Ata: what is the role of primary health care in achieving the Sustainable Development Goals?","volume":"392","author":"Hone","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bone.2019.115125_bib0105","series-title":"Osteoporosis: Fragility Fracture Risk","author":"National Clinical Guideline Centre","year":"2012"},{"key":"10.1016\/j.bone.2019.115125_bib0110","series-title":"NICE Impact","author":"National Institute for Health and Care Excellence","year":"2018"},{"key":"10.1016\/j.bone.2019.115125_bib0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11657-011-0063-y","article-title":"Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model","volume":"6","author":"Gauthier","year":"2011","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bone.2019.115125_bib0120","series-title":"Raloxifene and Teriparatide for the Secondary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"10.1016\/j.bone.2019.115125_bib0125","series-title":"Raloxifene for the Primary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"10.1016\/j.bone.2019.115125_bib0130","series-title":"Denosumab for the Prevention of Osteoporotic Fractures in Postmenopausal Women","author":"National Institute for Health and Care Excellence","year":"2010"},{"key":"10.1016\/j.bone.2019.115125_bib0135","series-title":"Bisphosphonates for Preventing Osteoporotic Fragility Fractures (including a Partial Update of NICE Technology Appraisal Guidance 160 and 161)","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"10.1016\/j.bone.2019.115125_bib0140","series-title":"Bisphosphonates for Treating Osteoporosis","author":"National Institute for Health and Care Excellence","year":"2017"},{"key":"10.1016\/j.bone.2019.115125_bib0145","author":"NHS Digital"},{"key":"10.1016\/j.bone.2019.115125_bib0150","series-title":"General Practice Prescribing Data","author":"Health and Social Care Information Centre","year":"2015"},{"key":"10.1016\/j.bone.2019.115125_bib0155","series-title":"Practice Level Prescribing Data","author":"NHS Digital","year":"2018"},{"key":"10.1016\/j.bone.2019.115125_bib0160","series-title":"Numbers of Patients Registered at a GP Practice (practice Level, 5 Year Age Groups)","author":"NHS Digital","year":"2018"},{"key":"10.1016\/j.bone.2019.115125_bib0165","series-title":"Census Data On Nomis","author":"Office for National Statistics","year":"2011"},{"key":"10.1016\/j.bone.2019.115125_bib0170","series-title":"of Lower Layer Super Output Areas in England and Wales","author":"Office for National Statistics: Rural Urban Classification","year":"2011"},{"key":"10.1016\/j.bone.2019.115125_bib0175","series-title":"English Indices of Deprivation","year":"2015"},{"key":"10.1016\/j.bone.2019.115125_bib0180","series-title":"EBM DataLab","year":"2017"},{"key":"10.1016\/j.bone.2019.115125_bib0185","series-title":"Denosumab for the Prevention of Osteoporotic Fractures in Postmenopausal Women","year":"2010"},{"key":"10.1016\/j.bone.2019.115125_bib0190","doi-asserted-by":"crossref","first-page":"k4675","DOI":"10.1136\/bmj.k4675","article-title":"Patients with type 1 diabetes are missing out on flash glucose devices, finds BMJ investigation","volume":"363","author":"Iacobucci","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.bone.2019.115125_bib0195","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-021312","article-title":"Trends, geographical variation and factors associated with prescribing of gluten-free foods in English primary care: a cross-sectional study","volume":"8","author":"Walker","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.bone.2019.115125_bib0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.2041-210x.2012.00261.x","article-title":"A general and simple method for obtaining R2 from Generalized Linear Mixed-effects Models","volume":"4","author":"Nakagawa","year":"2012","journal-title":"Methods Ecol. Evol."},{"key":"10.1016\/j.bone.2019.115125_bib0205","series-title":"Analyzing Health Equity Using Household Survey Data","author":"O\u2019Donnell","year":"2008"},{"key":"10.1016\/j.bone.2019.115125_bib0210","series-title":"The R Project for Statistical Computing","year":"2018"},{"issue":"7","key":"10.1016\/j.bone.2019.115125_bib0215","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/jbmr.3420","article-title":"Bisphosphonate drug holiday and fracture risk: a population-based cohort study","volume":"33","author":"Adams","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.115125_bib0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.maturitas.2017.04.008","article-title":"Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement","volume":"101","author":"Anagnostis","year":"2017","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.bone.2019.115125_bib0225","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jech-2017-209999","article-title":"Geographical epidemiology of health and overall deprivation in England, its changes and persistence from 2004 to 2015: a longitudinal spatial population study","volume":"72","author":"Kontopantelis","year":"2018","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.bone.2019.115125_bib0230","series-title":"Patient Choice of GP Practices","author":"England","year":"2018"},{"key":"10.1016\/j.bone.2019.115125_bib0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2431-9-69","article-title":"Why do paediatricians prescribe antibiotics? Results of an Italian regional project","volume":"9","author":"Moro","year":"2009","journal-title":"BMC Pediatr."},{"issue":"1","key":"10.1016\/j.bone.2019.115125_bib0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.healthpol.2005.09.009","article-title":"Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland","volume":"78","author":"Filippini","year":"2006","journal-title":"Health Policy"},{"issue":"4","key":"10.1016\/j.bone.2019.115125_bib0245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5414\/CP203032","article-title":"Geographic variations in antibiotic prescription for pediatric acute upper respiratory tract infections in South Korea","volume":"56","author":"Jung","year":"2018","journal-title":"Int. J. Clin. Pharmacol. Therapeutics"},{"issue":"1","key":"10.1016\/j.bone.2019.115125_bib0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s15010-009-9065-8","article-title":"Variability in outpatient antimicrobial consumption in Israel","volume":"38","author":"Nitzan","year":"2010","journal-title":"Infect."},{"issue":"5","key":"10.1016\/j.bone.2019.115125_bib0255","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/coa.13143","article-title":"Trends in the prescribing of topical nasal agents using an NHS England data base","volume":"43","author":"Saeed","year":"2018","journal-title":"Clin. Otolaryngol."},{"issue":"7","key":"10.1016\/j.bone.2019.115125_bib0260","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00198-015-3098-x","article-title":"Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010","volume":"26","author":"Klop","year":"2015","journal-title":"Osteoporos. Int."},{"issue":"11","key":"10.1016\/j.bone.2019.115125_bib0265","first-page":"997","article-title":"[Prevalence and distribution of genetic diseases in Quebec: impact of the past on the present]","volume":"23","author":"Laberge","year":"2007","journal-title":"Med. Sci."},{"key":"10.1016\/j.bone.2019.115125_bib0270","unstructured":"Organization, W.H.: Genomic resource centre. Genes and human disease. http:\/\/www.who.int\/genomics\/public\/geneticdiseases\/en\/index2.html. Accessed October 12th 2017."},{"issue":"7","key":"10.1016\/j.bone.2019.115125_bib0275","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4158\/EP161678.RA","article-title":"Clinical evaluation of cost efficacy of drugs for treatment of osteoporosis: a meta-analysis","volume":"23","author":"Albert","year":"2017","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.bone.2019.115125_bib0280","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2147\/CLEP.S164112","article-title":"Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on \"real-world\" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database","volume":"10","author":"Khalid","year":"2018","journal-title":"Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.bone.2019.115125_bib0285","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13018-018-0865-3","article-title":"Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis","volume":"13","author":"Wu","year":"2018","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.bone.2019.115125_bib0290","series-title":"Commissioning and Funding General Practice","author":"Addicott","year":"2014"},{"key":"10.1016\/j.bone.2019.115125_bib0295","series-title":"2019\/20 General Medical Services (GMS) Contract Quality and Outcomes Framework (QOF)","author":"Group, P.C.S.a.N.C","year":"2019"},{"key":"10.1016\/j.bone.2019.115125_bib0300","series-title":"Declaration of Astana","year":"2018"},{"key":"10.1016\/j.bone.2019.115125_bib0305","series-title":"Transformation and Corporate Operations - Business Planning Team","author":"NHS England","year":"2016"},{"key":"10.1016\/j.bone.2019.115125_bib0310","series-title":"Policy Perspectives on the Obsolescence of Health Technologies in Canada","author":"Elshaug","year":"2009"},{"key":"10.1016\/j.bone.2019.115125_bib0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhealeco.2019.02.001","article-title":"Healing the poor: the influence of patient socioeconomic status on physician supply responses","volume":"64","author":"Chen","year":"2019","journal-title":"J. Health Econ."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219304193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219304193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:47:09Z","timestamp":1757612829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219304193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":63,"alternative-id":["S8756328219304193"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.115125","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: A practice-level prescribing data analysis in 2013-2018","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.115125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115125"}}